When the enzyme in cell energy metabolism undergoes gene variations, the risk of developing prostate cancer is increased, claims a new study.
Researchers at the National Institutes of Health found that the genetic variations impair the enzyme phosphodiesterase 11A (PDE11A), which helps regulate cell's responses to hormones and other signals.
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemotherapy, cryosurgery or biologic therapy.
Advertisement
Previous studies by NIH researchers have linked genetic variations that inactivate PDE11A with increased susceptibility to testicular cancer and adrenal tumours.
The researchers found that a group of men with prostate cancer were nearly four times more likely to have variations affecting the activity of PDE11A than did men who did not have prostate cancer.
![Prostate Specific Antigen [PSA]]( "Prostate Specific Antigen [PSA]")
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commonly used to diagnose prostate cancer.
"Our study indicates that PDE11A one day may have a place in genetic screening for predisposition to prostate cancer," said senior author of the study, Constantine Stratakis.
The researchers examined tissue from 50 men with prostate cancer and 287 men who did not have prostate cancer.
The researchers analysed the DNA of the men and found 8 variations in the PDE11A gene that decreased the production or activity of PDE11A.
If the men with prostate cancer, 30 percent had one or more of these variations, compared with 10 percent of the men who did not have prostate cancer.
Of the variations the researchers detected, 5 had been detected in previous studies and 3 were previously unknown.
The findings were published online in the Journal of Clinical Endocrinology and Metabolism.
Source: ANI
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/300x250/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commonly used to diagnose prostate cancer.
Advertisement
"Our study indicates that PDE11A one day may have a place in genetic screening for predisposition to prostate cancer," said senior author of the study, Constantine Stratakis.
The researchers examined tissue from 50 men with prostate cancer and 287 men who did not have prostate cancer.
The researchers analysed the DNA of the men and found 8 variations in the PDE11A gene that decreased the production or activity of PDE11A.
If the men with prostate cancer, 30 percent had one or more of these variations, compared with 10 percent of the men who did not have prostate cancer.
Of the variations the researchers detected, 5 had been detected in previous studies and 3 were previously unknown.
The findings were published online in the Journal of Clinical Endocrinology and Metabolism.
Source: ANI
Advantages of Eating Fish Foods
Researchers worldwide have discovered that eating fish regularly is good for health. Regular consumption of fish may reduce the risk of diseases such as asthma, prostate cancer and eyesight.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Genetics & Stem Cells News
Relapsing-remitting multiple sclerosis has been successfully treated using autologous hematopoietic stem cell therapy.
Innovative discoveries in male hair loss research uncover uncommon genetic variants tied to it.
Researchers achieved a significant milestone in uncovering the genetic basis of dilated cardiomyopathy in Dobermanns.
Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.
Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.
